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Sudden cardiac arrest (SCA) is the leading cause of death in young athletes
(Drezner et al., 2007). The incidence of SCA in young athletes is a concern not only for
the medical community, but also for the community at large. Sudden cardiac arrest occurs
when electrical impulses in the heart become rapid or chaotic, which causes the heart to
suddenly stop beating. It is estimated that about 1 in 220,000 young athletes experience
sudden cardiac death (SCD) each year (Baggish et al., 2010). Competitive athletes are
considered to be one of the healthiest groups in society, and although sudden death
during sports is rare, its occurrence is generally widely reported in the media, due to the
age and apparently healthy condition of the athletes. The sudden and unexpected death of
a young athlete can devastate families, other young competitors, and the community
(Corrado et al., 2005). “Recent events in all parts of the world show that sudden cardiac
death (SCD) of athletes is still a reality and it continues to challenge experts in cardiology
which works with athletes” (Ferreira et al., 2010). When a young, seemingly healthy,
young athlete suffers SCA there is an outpouring of grief and disbelief, but the issue of
pre-participation heart screening does not gain traction. It is my contention that some
simple pre-participation screening, including a physical, an Electrocardiogram
(ECG/EKG), in addition to gathering an extensive family history, with a focus on
relatives who died from sudden cardiac arrest or who suffer from heart disease, could
have an enormous positive impact on this tragedy. In our family, we were fortunate that
our son survived a cardiac event during a college baseball game in 2004. An ECG
showed a cardiac abnormality, and subsequent testing revealed a diagnosis of a
progressive heart disease, Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
(ARVD/C). Although this diagnosis was a life-changing event for him, as well as for our
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family, it could have very well had a tragic ending. In this paper I will explore the
reasons pre-participation cardiac screening can be lifesaving for young athletes, as well
as highlight the value of screening in comparison to the costs involved.
The highest number of sudden cardiovascular death events recorded in any single
year was 76 (in both 2005 and 2006), followed by 66 in 1997 and 2002, and 64 in 1996
and 2001 (Maron et al., 2009). But these numbers are not reliable because there is no
national reporting system at this time in the United States. Maron writes, “Only a national
government–subsidized program with mandatory reporting, a centralized database, and
dedicated resources would be capable of establishing the precise incidence of sudden
death in young athletes in the United States.”
According to a 2005 article written by Dr. Dominic Corrado, and published in
The Lancet, “Genetic tests to allow for differential diagnosis are eagerly awaited. In the
meantime, electrocardiograms can either suggest or identify the presence of up to 60% of
the potentially lethal conditions associated with sudden death in athletes” (Corrado et al.,
2005). He believes that cardiovascular conditions that predispose to life-threatening
ventricular arrhythmias increase the risk for an athlete to suffer sudden cardiac death,
more than the sport itself.
A recent study conducted in the United States using computer models from
previous studies looked at the cost of adding electrophysiology testing to the usual preparticipation screening for athletes, compared to the benefits. It should be noted that the
American College of Cardiology and the American Heart Association recommend only
physical examination and a medical history be part of the pre-participation screening for
athletes, but the European Society of Cardiology and the International Olympic
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Committee believe the screening should include electrocardiography (ECG) to test for
abnormal heart rhythms. The study concluded that the costs, compared to the savings in
additional years of life, were well within what the US society is typically willing to pay
for health care tests or treatments (Wheeler et al., 2010).
Another study, conducted by University Health Services at Harvard University in
Cambridge, MA, studied 510 collegiate athletes who received cardiovascular screening
prior to sports participation. The objective of the study was to compare the performance
of pre-participation screening limited to medical history and physical examination with a
strategy that integrates these with ECG. Each participant had routine history and
examination-limited screening with ECG, and received transthoracic echocardiography
(TTE) to detect or exclude cardiac findings with relevance to sports participation. In this
study, cardiac abnormalities were observed in 11 of the participants with TTE. Screening
with history and a physical alone only detected 5 of these 11 participants.
Electrocardiography detected 5 additional participants with cardiac abnormalities (for a
total of 10 of 11 participants), thereby improving the overall sensitivity screening to
90.9%. There was, however, a false positive rate of 16.9%, compared to 5.5% for
screening with history and examination alone. The authors concluded that although a
definitive conclusion regarding the effect of ECG inclusion on sudden death rates could
not be made, adding ECG to medical history and physical examination improves the
overall sensitivity of pre-participation screening in athletes (Baggish et al., 2010).
In 2007, Stanford University added computerized ECG screening along with the
system-focused history and physical examination for its all athletes participating in
intercollegiate athletics. All information was entered into a database for measurement of
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the effectiveness of the addition of the ECG screening. The recordings were obtained
from athletes representing 24 sports. Although 68% of the women had normal ECGs,
only 38% of the men did. Of the 658 recordings that were obtained, sixty-three athletes
(10%) were judged to have distinctly abnormal ECG findings considered possibly
associated with conditions including Hypertrophic Cardiomyopathy (HCM),
Biventricular Hypertrophy (BVH), or Arrhythmogenic Right Ventricular
Dysplasia/Cardiomyopathy (ARVD/C). These athletes were offered further testing, but it
was not mandated according to research protocol. From the results of this study the
Stanford Sports Medicine program concluded that the mass ECG screening is achievable,
and that the rate of secondary testing suggests the need for an evaluation of costeffectiveness of mass screening as well as the development of a new athlete-specific ECG
interpretation algorithms (Le et al., 2010).
The cost effectiveness question is looked at in a recent article in The American
Journal of Medicine. The article looked at a recent study involving 964 student athletes
enrolled at the University of Kansas. All athletes underwent 12-lead ECG's as well as
echocardiograms. According to the authors, the concerns about cost effectiveness may be
somewhat mitigated by recent data which shows that ECG screening is associated with
2.1 life-years saved per 1000 athletes, an incremental cost of $89 per athlete, and a costeffectiveness ratio of $42,900 per life-year saved (Magalski et al., 2011). The article
points out that pre-participation cardiac screening, including a 12-lead ECG, is not
currently recommended or commonly performed in competitive athletes in the US due to
cost, resource limitations, as well as potential for false-positive results. The authors
believe that the study at the University of Kansas showed that this noninvasive screening
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did in fact find ECG abnormalities in 10% of the athletes, excluding some from
participation, and that no deaths have been reported in the population since the inception
of the study.
According to an editorial written by Dr. Barry J. Maron, there are two primary
prevention initiatives that have evolved to help create a safer athletic environment; preparticipation screening, and eligibility standards to prohibit athletes with identified
cardiac abnormalities from participating in competitive sports (Maron, 2010). According
to the Hypertrophic Cardiomyopathy Association website, Dr. Maron is the director of
Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation, and
also maintains the Sudden Death in Athlete U.S. Registry. The registry includes 1,866
athletes in 38 different sports who died suddenly or survived cardiac arrest throughout the
United States from 1980 to 2006. Of the deaths, 56% (1,049) were due to cardiovascular
disease, many of which could have been could have been detected with an ECG. Dr.
Maron asserts that “The low overall event rate reported should provide a general measure
of reassurance regarding sports participation, but underscores the need for mandatory
reporting of sudden deaths in young athletes” (www.4hcm.org).
Cardiologists in the US have looked at the mandatory national program in Italy
for screening all competitive athletes. The screening in Italy, which is federally
subsidized and began 27 years ago, includes a medical history, physical examination, and
a 12-lead ECG. Any athlete identified with a cardiovascular disease is disqualified from
participation. (According to a recent article in the Miami Herald, this screening program
has reduced sudden cardiac arrest by 89% among young athletes.) Maron states that
although there are some proponents of mass ECG screening here in the US, there are
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those who question the use of resources, complexity of implementation, and societal
influences. “A multitude of factors reinforce the impracticality of creating such a massive
and expensive governmental program within the U.S. medical system, confined to only
athletes and administered long-term.” He points out the there are a larger number of
athletes in the United States who participate in high school and college sports programs,
estimated at 15 million, and that although sudden deaths of young athletes is tragic, these
events are uncommon in this country (fewer than 100 annually). Maron adds that there
are a high number of false-positive ECG results (10%-20%), which ultimately promote
inappropriate disqualifications, and unnecessary anxiety. He also believes the perception
by some that the disqualification from sports would represent an infringement on
individual liberty, and the freedom to assume personal risks, even for sudden death.
Finally, he does not believe it is logistically possible to offer this testing to all young
athletes; physician resources simply do not exist in this country. He concludes that
although the ECG is a simple test, there are too many obstacles that prohibit the creation
of a mandatory pre-participation screening program with ECG for young persons in
competitive sports in the US (Maron, 2010).
Dr. Steven Fera, a Cardiologist practicing in Rhode Island, and an Assistant
Professor of Medicine, Warren Alpert School of Medicine at Brown University, agrees
with the current recommendations of the American College of Cardiology (ACC). He
added that pre-participation cardiac screening is a topic that has been a great concern for
pediatricians, educators, and policy makers. He believes the cost of screening everyone is
quite high, and the yield is too low to be felt to be cost-effective by contemporary
standards. He adds that minor abnormalities, which are commonly detected in this
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screening, generate extreme anxiety and frequently lead to more costly and unnecessary
testing. The ACC and others believe that a good family history and physical, with
attention to any suspicious symptoms, findings on exam, and inquiring about a family
history of unexplained sudden death or other unusual heart disease patterns. ECG and
Echocardiogram would be ordered selectively based on these exams. He added, “I see the
primary barrier to screening in the US as cost and liability. Training team physicians and
similar non-cardiologist providers to provide these services and interpret EKGs may go a
long way in expanding these services” (Fera, S., December 2012).
A study conducted by the Department of Cardiology at Tel Aviv University,
Israel sought to estimate the cost of a national electrocardiographic (ECG) screening of
athletes in the United States and the number of lives that would be saved by the program.
The cost-projection model was based on the Italian study, and the size of the screening
population was estimated from data provided by the National Collegiate Athletic
Association (NCAA) and the National Federation of State High School Associations. The
costs of diagnostic testing were obtained from Medicare reimbursement rates. The results
of the study showed that a 20-year program of ECG screening of young competitive
athletes in the United States would cost between $51 and $69 billion, and could be
expected to save 4,813 lives. Accordingly, the cost per life saved is likely to range
between $10.6 and $14.4 million. Their conclusion was that replicating the Italian
strategy in the US would result in enormous costs per life saved (Halkin et al., 2012).
However, if your child is one that is saved by pre-participation cardiac screening, is there
any price that seems too much to pay for their life? Also, does it make sense to use
reimbursement rates from Medicare for the study, when those rates could be excessive?
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Dr. Robbie Foy, of the University of Leeds, UK, disagrees with Maron’s
assertions, using data from his experience with a screening program in suburban Chicago.
The program, Young Hearts for Life, began in 2006, and has screened more than 45,000
high school athletes. He writes that although there are a larger number student athletes in
the US than Italy, as a percentage of the population US athletes number about half that of
Italy (5% in US vs. 10% in Italy). He added that the number of primary care physicians is
about the same per capita in both countries. Foy also questions Maron’s estimate of the
number of sudden cardiac deaths annually. He writes that the statistic of less than 100
deaths per year is not based on a scientific registry like the Italian data, but merely on
media reports. The concern about the high incidence of false-positive ECG interpretation
is overstated in his view; he cites contemporary standards of 5% or less. He goes on to
add that similar issues have not impeded testing in other areas of medicine (ex.
mammography, and phenylketonuria screening in newborns). “The medical community’s
approach has always been to pursue improvements that reduce the false-positive rate
through refinement in techniques and experience. It should be no different with ECG
screening…Solutions to problems are not found by saying how we cannot achieve a
worthy goal, but rather by asking how we can. Until we change this mindset, we will
continue to unnecessarily lose too many of our precious youth to potentially preventable
causes of sudden death” (Foy, 2010).
Dr. Corrado also points out in his article that a parallel study done in Italy showed
that there were no deaths in symptom-free athletes who were correctly diagnosed with a
hypertrophic cardiomyopathy and disqualified from competitive sports. The study proves
that the identification and restriction prevented sudden death (Corrado et al., 2005). He
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adds that because sudden and unexpected death in young athletes is such a devastating
tragedy we should make every effort to increase awareness and implement
comprehensive screening strategies to eliminate the risk.
At an August, 2012 meeting of the European Society of Cardiology Congress, Dr.
Andrea Menafoglio of Switzerland reported that cardiovascular screening with ECG is a
cost effective way of diagnosing cardiac abnormalities. Dr Menafoglio stated that at a
cost of just €115 (~$150) per athlete, can prevent a substantial proportion of tragic
cardiac deaths. Using data collected from a program in Switzerland that assessed
competitive athletes aged 14-35 years using personal and family history, physical
examination, and resting ECG. Between February 2011 and April 2012, 1070 athletes
were examined. A total of 6.3% athletes required further examination, most due to
abnormal ECG. A new, previously unknown, cardiac abnormality was found in 2% of the
athletes. Without ECG, only .8% of the athletes would have been referred for further
testing. He added that, even with the relatively high cost of medical services in
Switzerland, cardiovascular screening with ECG of young athletes is feasible with few
subsequent examinations, and at a low cost (http://www.medicalexpress.com/news)
If a child is diagnosed with a heart condition, there are many precautionary steps
that can be taken to prevent the likely outcome of SCA including lifestyle modifications,
medications, surgical treatments, and implanting a pacemaker and/or implantable
Cardioverter defibrillator (ICD). Guidelines are available for the management of athletes
with an identified cardiovascular disease in order to provide doctors with advice on the
type and degree of sports activity that can be safely done by the individual (Corrado et
al., 2005).
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“The Implantable Cardioverter-Defibrillator (ICD), although initially designed as
a treatment for older patients with coronary artery disease, has more recently proved to be
a safe and effective therapeutic intervention in young patients with HCM, both for
primary or secondary prevention of sudden death” (Maron & Spirito, 2008). They cite
that the ICD was developed in the early 1980’s by Drs. Michael Mirowski and Morton
Mower, but it was not used for primary prevention until the 1990s. A number of
controlled and randomized tests over the last 20 years have shown it to be superior to
conventional antiarrhythmic medical treatments for both primary and secondary
prevention of SCD. Finally, “Although definitive data are lacking and will require
decades of observation to assemble, the available experience suggests that selected HCM
patients protected from SCD by the ICD could potentially survive many decades of
productive life, and even achieve normal or near-normal life expectancy, if not
encumbered by other major HCM-related disease complications” (Maron & Spirito,
2008).
In a 2011 article published in Circulation, the authors believe that a more precise
estimation for primary (screening) and secondary (emergency response planning) be
considered. They conducted a study from January 2004 – December 2008, of all cases of
sudden death in NCAA student-athletes. They utilized an NCAA database, weekly
systematic search of public media reports, and catastrophic insurance claims. During this
time period 273 deaths were reported, 187 (68%) were due to nonmedical or traumatic
cases, 80 (29%) to medical causes, and 6 (2%) to unknown causes. Cardiovascularrelated sudden death was the leading cause of death in 45 (56%) of the medical cases, and
represented 75% of sudden deaths during exertion (Harmon et al., 2011). In their
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conclusion they note that SCD is the leading medical cause of death in NCAA athletes,
and that it occurs at a much higher rate than previously accepted. They believe that better
methods of case identification should be developed. Because the study showed a higher
incidence of SCD among black athletes and among basketball players, they believe that
these high-risk athletes must be considered for ECG screening.
Since 2011, the NFL has included cardiac testing to their Scouting Combine.
According to Richard Kovacs, MD, professor of clinical medicine at the Indiana
University School of Medicine and clinical director of the Krannert Institute of
Cardiology, “each year tests reveal problems serious enough for two or three players to
be red-flagged as possibly needing additional evaluation before they can participate in the
scouting combine workouts.” This year at the combine in Indianapolis, 300 college
football players received electrocardiograms and echocardiograms to determine whether
any of them have anomalies that have gone undetected to this point in their athletic
careers. The testing results are delivered to the NFL medical staff; the evaluators don’t
make recommendations, leaving the decisions regarding further testing to the NFL. The
testing was conducted at the IU Health Methodist Hospital using loaned equipment and
volunteer staff so as not to interfere with hospital operations. According to Dr. Kovacs,
“about 400 athletes at all levels of sports die on the field or court each year in the United
States, with an undetected cardiac anomaly being the most common cause.” Although he
is not sure whether screening everyone is the answer, Dr. Kovacs and his colleagues will
meet with NFL officials to evaluate the screening program to see that it provides useful
information in a cost-effective manner. (http://communications.medicine.iu.edu)
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According to an August 8, 2012 article in the Miami Herald, “Screenings with
EKG urged to protect young athletes from sudden cardiac death,” sudden cardiac death
claims about 500 young lives every year in the United States. The author, Howard Cohen,
states, “In the U.S. there’s a feeling there’s a cost and it’s not cost-effective. But if you
are a family who has lost a child, statistics don’t matter. In the U.S. we have the ability to
identify more children who are at risk for sudden death but we don’t implement it.” He
cites the Italian screening program and adds, in Japan screenings of the heart are
mandatory for all students entering school, regardless if they are athletes. Because their
data indicates every three days in the United States a young student athlete dies from
sudden cardiac death (SCD) and experiences no prior symptoms, earlier this year the
Miami Children’s Hospital began offering free EKG screenings to all middle and high
school sports participants. If they can diagnose and potentially save a child in
adolescence, they believe it will add 40-60 years to their life. The cost of the screening is
approximately $50 - $100 per child, but if a mass program were instituted, it is expected
the cost would drop to $10 per child. Dr. Victoria Vetter believes that improvements in
technology will reduce the current ECG costs. And she supports further studies to address
the cost-effectiveness issue. She states there should be a commitment to obtain relevant
data that will be accepted as applicable in the United States, with cost utility analysis,
ones that can be supported with trials and scientific data (Vetter, 2009). I believe that if
hospitals like Miami Children’s Hospital can offer free screening, the idea that the cost to
test high school and college athletes would be prohibitive, loses its meaning.
According to an August, 2012 article in The American Journal of Medicine,
physicians need to understand that educational institutions have a responsibility to
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student athletes regarding sudden cardiac deaths on the athletic field. It outlines medical
and legal issues confronting physicians in the cardiovascular evaluation of competitive
athletes. The authors believe that a better understanding of the roles of the physician can
help protect themselves and the colleges from liability for negligent medical care. It is
their contention that physicians involved with eligibility decisions in athletes with
cardiovascular disease and pre-participation screening may assume some risk of liability.
Finally, they believe that only a prospective, longitudinal study examining the impact of
pre-participation ECG and cost-effective echocardiography will end the ongoing debate
regarding the best way to reduce sports-related sudden cardiac death (Paterick, et al,
2012).
A 2009 article in Pace discusses pre-participation screening and pre-participation
forms, and focuses on the lack of understanding in previously written articles. A quote
from a 1996 study said there was limited value in pre-participation evaluation (PPE) for
the identification of underlying cardiovascular abnormalities. But Dr. Robert Campbell
disagrees and notes that over the past decade the knowledge around SCD and the role of
PPE patient and family questionnaires, as well as a physical examination needs to be
reevaluated (Campbell, 2009). Dr. Campbell believes that many patients affected by
structural, functional, or primary electrical cardiac conditions making them predisposed
to SCD, could be identified by a comprehensive and diligent PPE. He asserts that asking
the family the right questions, in the right way, regarding patient/family history is critical;
families must be educated on early warning signs and must take responsibility for the
details of family history. In our family’s case, only after the diagnosis was made did the
Cardiologist asked a series of questions regarding Neil’s history, as well as family history
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regarding heart disease and SCD. At no time prior to this were we asked any questions
along these lines, even though Neil played three sports in high school, and baseball in
college. All that was required for participation in school sports was a physical performed
by a physician. Although there were no cases in our families to link to Neil’s disease,
upon questioning Neil admitted to previous warning signs while participating in sports in
high school. Neil had never reported any of these events to us, or to his doctor or a coach.
It is my contention that it difficult to rely on this type of screening alone because this
information is not regularly being sought prior to participation, not everyone has
extended family health information, and it may not be enough to rely on a young athlete
to relay previous events. Oftentimes an athlete, such as in Neil’s case, would think that
shortness of breath or dizziness could be attributed to overexertion. The Hypertrophic
Cardiomyopathy Association has available on its website a downloadable Risk
Assessment Form, which was created using recommendations from the American Heart
Association, to help identify those at risk for sudden cardiac arrest (www.4hcm.org).
In a 2010 article in Wiley Periodicals, the authors write, “There are several minor
coronary artery malformations which are harmless at rest, but can become fatal with
exercise” (Smulevitz et al., 2010). According to the article 12% of sudden deaths among
athletes are caused by these coronary anomalies. These coronary abnormalities differ
from the previously discussed heart diseases that can cause deadly arrhythmias. To make
their point they use the case of a sixteen-year old high school football player who
experienced chest pain, but had normal blood pressure and ECG, and had no family
history of myocardial infarction (heart attack). Only through the use of echocardiography
was it confirmed that the athlete had an artery malformation. He was treated medically
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and restricted from strenuous sports activity. They summarize by saying that limited echo
imaging, in a cost effective manner, should be part of a comprehensive screening
program for athletes.
An article in the most recent edition of Current Opinion in Cardiology, the
authors reviewed the recent literature and recommendations for cardiovascular screening
in young athletes. They pointed out that studies demonstrate the traditional history and
physical-based examinations have a limited sensitivity, and do not detect the majority of
athletes with at-risk conditions. They believe this may provide false reassurance for
athletes with disorders that remain undetected. They continue, “Electrocardiogram (ECG)
screening increases the sensitivity of the examination to detect disease, and cost modeling
suggests protocols inclusive of ECG are the only screening strategies to be cost-effective”
(Asif et al., 2013). The authors conclude that in order to avoid high false-positive rates it
is essential that proper ECG interpretation that distinguishes physiological cardiac
adaptations in athletes from findings suggestive of underlying cardiac pathology be
utilized, and that greater physician education and research are needed for improvements
to be made in the pre-participation examinations of athletes.
Because we lack a consensus in the medical community regarding preparticipation heart screening in the United States, what can be done to protect young
athletes from sudden cardiac death? According to an article in Heart Rhythm, every
school or institution that sponsors athletic activities should have a written emergency plan
in place. The plan should be coordinated with the local Emergency Medical Services
personnel, and be reviewed with each individual coach, athletic trainer, team physician,
school safety personnel, and administrators (Drezner et al., 2007). Prompt recognition of
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SCA is critical, and they add that any collapsed athlete who is unresponsive requires
immediate assessment for SCA. Often SCA is misdiagnosed as a seizure and is not
treated appropriately. In my son’s case, he did not suffer SCA, but the cardiac event he
experienced was diagnosed as a panic attack, even though he had never experienced one
in the past. Even after an examination Neil’s own physician did not refer him for further
cardiac assessment. The fact that I work for a Fire Department with highly trained
Emergency Medical Technicians may well have saved my son’s life. When I spoke with
a couple of them after the incident they strongly recommended I follow-up with a
cardiologist. Trusting their judgment I requested an appointment for cardiac testing.
Subsequently, Neil was diagnosed, placed on cardiac medication, and underwent surgery
for the implantation of an Implantable Cardioverter-Defibrillator. Needless to say,
competitive sports are no longer an option for him, but he knows he is lucky to be alive.
In his words:
When I look back at the time of my diagnosis, I realize I was naive about
it; I didn’t know how much it would change my life. I thought the hardest
part was giving up playing baseball. But since I have lived with an ICD,
and have experienced receiving shocks from it, I know that is the hardest
part of the disease for me. Each time I receive a shock it takes time to
recover physically and psychologically from it. In my mind I know I am
fine, but I am nervous about the likelihood of a future event. The high
heart rate does not make me afraid of dying while exercising, but I fear the
pain of the shock. It reminds me that I no longer have control of my body
and that is very hard to deal with (Harrington, N., December 2012).
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With what I have learned since Neil’s diagnosis, I believe that all school coaches
and training staff should be trained in Cardiopulmonary Resuscitation (CPR), and have
an AED available to be used by trained staff. Currently sixteen states have laws requiring
or supporting schools have AEDs on site. According to the American Heart Association
89 percent of people who suffer an out-of-hospital cardiac arrest die because they don’t
receive immediate CPR from someone on the scene; cardiac arrest survival falls an
estimated seven percent to ten percent for every minute without CPR. Defibrillation is the
delivery of electric shock to restore the heart’s normal rhythm. Early use of an AED is
considered to be one the most critical link in the chain of survival for a victim of SCA.
AEDs are lightweight, sturdy, and easy to use by anyone with training.
We do not have to look far to find cases of SCD in young athletes. In May 2005,
Michael Monteleone, a 9th grade baseball player at Lincoln High School died while
running at baseball practice. Michael was a healthy young person who excelled at sports,
and was an honor student. A coach started CPR on Michael but was unable to revive him.
There was no AED available at the field during athletic events. An autopsy determined
that Michael had ARVD, which was undiagnosed at the time of his death
(http://heartsafeaed.org/). Michael’s family went on to start a foundation, which helped
schools and youth sports groups throughout Rhode Island purchase AEDs.
In 2007, the American Heart Association in collaboration with the Rhode Island
Department of Health’s Heart Disease and Stroke Prevention Program created the Rhode
Island HeartSafe Community Program. The initiative is based on the idea that lives can
be saved by being prepared with prevention, early access to care, early CPR, early
defibrillation, and early advanced care. The program uses a system of points, called
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HERATBEATS, that a community earns by conducting CPR/AED training sessions in
the community, equipping local law enforcement with AEDs, instituting effective
emergency response plans in schools and municipal buildings (that may include CPR and
AED), placing AEDs in the community (with appropriate trained personnel), dispatching
Advanced Life Support with 12-lead ECG capability to appropriate emergencies, and
having an ongoing process to evaluate and improve the “Chain of Survival” and overall
cardiac health in the community. To date, five communities in Rhode Island have reached
the goal of being named a HeartSafe Community: Westerly, Warwick, South Kingstown,
East Providence, and Coventry. It has been a rewarding experience for me to serve on
both the Heart Disease and Stroke Prevention EMS task force, as well as the East
Providence HeartSafe Community Committee.
We do not have to wait for more information in a registry to determine how many
young lives are lost, and families changed forever, before we make changes to the preparticipation screening of young athletes in this country. There is plenty of
documentation regarding preventative testing for diseases that have had a positive impact
on survival rates. The implementation of mammography and colonoscopy, for example,
in diagnosing diseases in their early stages has saved many lives, and most insurance
companies cover the cost of these tests, although some patients will have a co-pay. Many
physicians already own the ECG equipment in their offices, so patients do not need to
travel to a testing center to have the test completed. In addition, often a technician in the
practice completes the testing, so the physician does not need to spend additional time on
the appointment; the doctor can later do the analysis of the readout, and make
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recommendations to the patient. Many health insurance plans cover the cost of ECG
screening, although some require a co-pay.
Pre-participation cardiac screening of young athletes will save lives, and the
longer we wait to gather statistics the more lives will be lost, and more families and
communities devastated. The time to act is now. With the information currently available,
a convincing argument can be made that saving a young athlete is worth the cost of
screening, especially if that child is your own.
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